Zhejiang East Asia Pharmaceutical Co., Ltd. Class ASSE: 605177

Announcement on Wholly-owned subsidiary's Obtaining Registration Certificate for Drug Substance of Cefditoren Pivoxil from the Republic of Korea

· Issued by Zhejiang East Asia Pharmaceutical Co., Ltd. Class A via Shanghai Stock Exchange
Announcement on Wholly-owned subsidiary's Obtaining Registration Certificate for Drug Substance of Cefditoren Pivoxil from the Republic of Korea

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Company analysis